1992
Severe gingival overgrowth associated with cyclosporine and verapamil therapy
Perkal M, Gulino D, Delfini R, Siegel N, Gaudio K, Marks W, Lorber M. Severe gingival overgrowth associated with cyclosporine and verapamil therapy. Clinical Transplantation 1992, 6: 399-402. DOI: 10.1111/j.1399-0012.1992.tb01118.x.Peer-Reviewed Original ResearchGingival hyperplasiaAntihypertensive therapyTransplant recipientsOperative interventionSide effects of cyclosporineCadaveric renal transplant recipientsCsA dose reductionRenal transplant recipientsRecommended therapeutic strategiesOrgan transplant recipientsExcellent early resultsRoot planingGingival overgrowthGingival diseaseVerapamil therapyDose reductionRenal transplantationApproximately 1 yearTherapeutic strategiesHyperplasiaTherapyPatientsGingivectomyVerapamilCyclosporine
1991
Cyclosporin A renders target cells resistant to immune cytolysis
Hudnall S. Cyclosporin A renders target cells resistant to immune cytolysis. European Journal Of Immunology 1991, 21: 221-226. PMID: 1846819, DOI: 10.1002/eji.1830210133.Peer-Reviewed Original ResearchConceptsCsA dose reductionB-cell hyperplasiaB lymphocytesDose reductionCell growth inhibitionNatural killerCell hyperplasiaEarly post-transplant lymphoproliferative disordersHuman organ transplant recipientsPost-transplant lymphoproliferative disorderT cell-dependent responsesAntibody-dependent responsesPost-transplant settingOrgan transplant recipientsTarget cellsEpstein-Barr virusCell-dependent responsesHuman target cellsComplement-mediated cytolysisGrowth inhibitionTransplant recipientsDisease regressionImmune controlNK cellsLymphoproliferative disorders
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply